Chemicals management plan (Horizontal initiative)

On this page

General information

Name of horizontal initiative

Chemicals Management Plan

Lead department

Health Canada

Federal partner organizations

Start Date

2007-08

End Date

2023-24 (The CMP was renewed for an additional two years in Budget 2024. Updated information will be available in future reports.)

Description

The objective of the Chemicals Management Plan (CMP or "the Program") is to protect human health and the environment by addressing substances of concern in Canada. It was launched in 2006 and is jointly managed by Health Canada and Environment and Climate Change Canada (ECCC). The Public Health Agency of Canada (PHAC) also contributes to this Program.

The core functions of the Program are: 1) chemicals risk assessment; 2) chemicals risk management, compliance promotion and enforcement; 3) research, monitoring and surveillance; and 4) collaboration, outreach and engagement.

The CMP addresses both substances currently in commerce ("existing substances") and substances entering the Canadian market ("new substances"). It also takes into consideration various routes of exposure (e.g., from water, air, food, consumer products, cosmetics, pesticides, etc.), and both chronic and acute risks. When identifying and/or managing risks, actions are guided by the Canadian Environmental Protection Act, 1999 (CEPA), the Canada Consumer Product Safety Act (CCPSA), the Food and Drugs Act (F&DA), the Pest Control Products Act (PCPA) and others, as appropriate.

For more information, see the Government of Canada's Chemical Substances Portal.

Governance structures

Health Canada and ECCC share the overall responsibility for delivering the CMP. The Departments fulfill their responsibilities through established internal departmental governance structures, as well as a joint CMP governance structure to address shared responsibilities.

Within the joint structure, there is a CMP Horizontal Initiative Oversight Committee comprised of implicated Assistant Deputy Ministers (ADMs) from the three partner organizations. Meetings of the CMP Horizontal Initiative Oversight Committee are co-chaired by the ADM of the Healthy Environments and Consumer Safety Branch, Health Canada, the ADM of the Environmental Protection Branch, ECCC, and the ADM of the Science and Technology Branch, ECCC. This Committee provides strategic direction and management oversight for the integrated delivery and management of the CMP. This Committee will also resolve any disputes within the Horizontal Initiative. This Committee reports to the Deputy Ministers of Health Canada and of ECCC and is responsible for the overall management of the CMP. It meets approximately four times a year.

The CMP Horizontal Initiative Oversight Committee is supported by the CMP Steering Committee, which consists of all implicated Directors General (DGs) within Health Canada and ECCC. The CMP Steering Committee also meets four times a year, although some DG sub-groups meet monthly. The CMP Steering Committee provides a regular open exchange of information and makes decisions on a broad range of operational and policy issues for the implementation of CMP.

The CMP Steering Committee is supported by a CMP Working Group, a director-level committee that meets every two weeks to provide oversight of the CMP's implementation and coordination, and seeks to resolve issues that may arise, while developing options and making recommendations to DGs as needed. Overall, this joint CMP governance structure supports integration, co-ordination, decision-making, and clear accountabilities within the Horizontal Initiative.

Total federal funding allocated from start to March 31, 2024 (dollars)

$1,785,865,593

Total federal funding planned spending to March 31, 2024 (dollars)

$1,785,865,593

Total federal actual spending to March 31, 2024 (dollars)

$1,740,855,519

Date of last renewal of initiative

June 2021 (Note: the CMP was renewed in Budget 2024. Updated information will be available in future reports.)

Total federal funding allocated at the last renewal and source of funding (dollars)

$477,686,192 (Budget 2021)

Additional federal funding received after last renewal (dollars)

Not applicable.

Total planned spending since last renewal

$477,686,192

Total actual spending since last renewal

$474,150,759

Fiscal year of planned completion of next evaluation

Evaluation completed in 2023-24. Next evaluation of the renewed CMP will be in 2028-29.

Performance highlights

In 2023-24, the Program:

Further details on 2023-24 achievements under the four themes of the CMP are outlined below.

Performance details

Chemicals risk assessment

In 2023-24, assessments for 161 existing substances were published, including seven Final Assessments (representing 44 substances), and eight Draft Assessments (representing 117 substances). Since its inception, the Program has addressed approximately 99% of the 4,363 existing substances that were originally prioritized for assessment under the CMP. The Existing Substances Program completed a total of 294 inquiries related to existing substances from April 1, 2023 to March 31, 2024.

The Identification of Risk Assessment Priorities (IRAP) approach was used as a basis to select and propose assessment priorities for the new Plan of Priorities being developed under CEPA section 73.

Regarding new substances, 277 new substance notifications were assessed in 2023-24 under the New Substances Notification Regulations (231 chemicals and polymers, and 46 animate products of biotechnology). The New Substances Program completed a total of 722 inquiries related to new substances from April 1, 2023, to March 31, 2024.

Nineteen pesticide post-market reviews were also completed (17 re-evaluations and 2 special reviews).

Chemicals risk management

In 2023-24, ECCC and Health Canada published 11 risk management instruments for existing substances deemed harmful to human health and/or the environment in order to manage the risks they pose (ten proposed instruments and one final risk management instrument). For example, the proposed Certain Products Containing Toxic Substances Regulations would prohibit the manufacture, import and sale of certain coal tar-based sealant products and certain sealant products containing PAH levels above 1 000 ppm in order to prevent harmful ecological impacts and to help reduce the risk of adverse health impacts resulting from exposure to these toxic substances in Canada. Since the launch of the CMP in 2006, risk management measures for toxic substances have more than doubled from about 200 in 2006, to over 400 in 2024. Risk management work is cumulative in nature, as the implementation and administration of existing instruments must continue even as new risk management measures are developed.

This risk management for existing substances included one Significant New Activity (SNAc) Notice of Intent for three existing substances. SNAc provisions trigger an obligation to provide the Government of Canada with information about a substance prior to a significant new activity.

In addition, seven risk management scope documents and three risk management approach documents were also published. In general, these documents outline the Government's plan for managing the risks from the substance(s) and provide an opportunity for stakeholders to inform the path forward.

Regarding new substances, nine had risk management instruments imposed within mandated timelines (one SNAc Notice and eight Ministerial Conditions were issued) in order to ensure that new substances assessed to be potentially harmful do not enter the Canadian marketplace without appropriate control measures to mitigate risks to human health or the environment. Eighteen orders were published in the Canada Gazette, Part II, adding 122 substances to the Domestic Substances List and seven orders were published in the Canada Gazette, Part I, deleting 16 of these 122 substances from the Non-domestic Substances List. Substances cannot be on both the Domestic Substances List and the Non-domestic Substances List simultaneously because the two inventories are associated with different regulatory requirements.

There have not been any new publications of performance measurement evaluation reports, however eight draft evaluations were either started or continued. The 2020 Performance Measurement Evaluation Strategy continues to be implemented to provide Canadians with information on the effectiveness of risk management actions in place for toxic substances. Evaluations are being conducted in accordance with the external rolling workplan, which provides a high-level workplan of performance measurement evaluations currently underway or to be initiated in coming years.

Health Canada also published seven final and draft guidelines and guidance documents for drinking and recreational water quality, which are used by all jurisdictions in Canada as the basis for their drinking water quality requirements and to inform their recreational water quality requirements.

In 2023-24, Health Canada expanded the use of the X-Ray Fluorescence Analyzer (XRF) during onsite establishment inspections of consumer products and cosmetics to screen for the presence of substances of concern, including: lead, cadmium, mercury, antimony, barium, arsenic, and selenium. In addition, the Product Safety Lab completed the development and validation of new test methods for: the identification of phenol in cosmetics; flame retardants in building material, foam pillows and children's products; and the compositional analysis of neem oil.

PHAC continued its risk-based public health inspection program to identify and mitigate human health risks associated with water, food, and sanitation on board passenger conveyances and their ancillary services to protect the travelling public.

ECCC participated in a seminar series presented by international organizations related to the management of hazardous substances in port areas. The seminars provided authorities from different countries an opportunity to share and learn about port operations, different types of regulatory regimes, key risk management considerations, and good practices.

ECCC and Health Canada are active members of a number of Working Parties of the Organisation for Economic Co-operation and Development (OECD) including the Chemicals and Biotechnology Committee, the Working Party on Risk Assessment, the Working Party on Risk Management and the Working Party on Chemical Accidents.

Health Canada serves as the head of the Canadian delegation to advance Canada's priorities to strengthen collaboration and promote understanding of global health and environmental issues of priority to Canada and support Canada's engagement with the OECD on horizontal and international policy initiatives related to chemicals risk management.

As an active member of the OECD Working Party on Chemical Accidents, ECCC participated in updating the Decision-Recommendation concerning Chemical Accident Prevention, Preparedness and Response along with the related Guiding Principles. These documents were updated to address emerging issues and incorporate elements related to lessons learned from past chemical accidents, with the objective to better guide and align member countries in the amendment or development of their own legal frameworks.

Compliance promotion and enforcement

In 2023-24, ECCC's CMP compliance promotion activities focused on pollution, including the release of toxic substances to air, water or land, and the import and export of hazardous waste that presents a risk to the environment and/or human health. These activities aimed to increase voluntary compliance with regulatory and non-regulatory instruments, thereby mitigating consequential enforcement actions. A total of 13,552 known or potential regulatees received compliance promotion awareness materials from ECCC, and 882 stakeholders contacted compliance promotion officers for clarification of regulatory requirements and/or additional information. ECCC conducted 784 enforcement activities related to CMP regulations and issued 210 enforcement measures.

ECCC also promoted the Environmental Emergency Regulations, 2019 to a wide array of stakeholders at 25 venues across Canada, in addition to responding to 1037 inquiries related to the regulations.

In 2023-24, in addition to publishing the Annual Compliance and Enforcement Report for 2021-2022 which included summaries of compliance and enforcement actions on chemical-related projects, Health Canada published Enforcement Summary Reports for various compliance verification projects on consumer chemical products. These projects verified compliance for p-Phenylenediamine in cosmetics, Thioglycolic Acid (TGA) and its salts in cosmetics, cosmetic tattoo ink, and requirements under the Consumer Chemicals and Containers Regulations, 2001 (CCCR, 2001). Compliance verification projects were initiated in 2023-24 for consumer chemical products under the CCCR, 2001, cosmetics in pressurized containers, Tris(2-chloroethyl) Phosphate (TCEP), cyanoacrylate in cosmetics, surface coating materials on home furnishing products, glazed ceramics and glassware, consumer products containing lead and phthalates, and boric acid in toys.

Research

In 2023-24, Health Canada conducted 24 research projects to address priorities identified by CMP partners. This includes six collaborative research agreement projects, three ongoing projects and the funding of 15 new research proposals to support the following research themes:

  1. Environmental Health Research for CMP Priority Chemicals, Mixtures or CEPA substances
  2. Monitoring and Surveillance of CMP Priority Chemicals
  3. New Approaches and Methodologies for the Assessment of CMP Priority Chemicals, Mixtures or CEPA substances

For example, research was conducted to measure firefighters' exposure to polycyclic aromatic hydrocarbons (PAHs) during live fire training to inform chemical exposure levels of firefighters. In addition, research was conducted on per- and polyfluoroalkyl substances (PFAS), including the use of new approach methodologies to address multiple PFAS simultaneously, to advance the understanding of the potential human health impacts of exposure.

At ECCC, activities were conducted as part of 19 research projects funded by CMP. Of the 19 projects selected, three are related to fate and exposure in the atmospheric media, seven are studying substances' behaviour from a wildlife perspective, eight are targeting the aquatic environment and one is a joint project involving researchers specialized in multiple media. Nine of the projects are related to mixtures of contaminants and would give some preliminary scoping basis to elaborate a structured and collaborative multi-media approach to examine complex mixtures in real-life hotspots. Several research projects focus their attention on PFAS, a high priority grouping of substances for the CMP. Three research projects advance knowledge of nanomaterials, their behaviour in the environment, exposure, hazard, and bioaccumulation; and one research project is related to biotechnologies, proposing to use bioinformatic strategies to characterize microbial consortia. Finally, a few of these projects are focused on the development of new analytical methods, for instance to characterize PFAS, chlorinated alkanes and chemical mixtures in air.

The research activities aimed to:

Monitoring and surveillance

The Maternal-Infant Research on Environmental Chemicals (MIREC) Research Platform continued the assessment of prenatal exposure to chemicals and established national estimates of maternal and fetal exposures. In 2023-24, a follow-up study to MIREC called MIREC-ENDO continued Phase 2 and prepared for Phase 3. MIREC-ENDO is studying the effects of prenatal exposure to environmental chemicals on puberty and metabolic function in children, as well as maternal health in later years.

Since 2007, nationally representative biomonitoring data have been collected through the Canadian Health Measures Survey (CHMS). The levels of environmental chemicals are reported for the Canadian population and disaggregated by age and sex. In 2023-24, the CHMS continued collecting information on the gender identity of respondents and a new potentially disproportionately impacted sub-population (1-2 years of age). In August 2023, the Canadian Biomonitoring Dashboard was launched on the Health Infobase platform. The dashboard shows levels of environmental chemicals in the Canadian population, as measured through the CHMS.

New and updated environmental chemical biomonitoring fact sheets were also released in August 2023, to provide additional contextual information for the general public on the health impacts of specific chemicals and their use in Canada (e.g., DEET, glyphosate, PFAS).

As part of the Northern Contaminants Program (NCP), seven human biomonitoring and health project proposals were funded to monitor contaminant levels in wildlife and people in the Canadian North. The NCP also provided support for the Global Atmospheric Passive Sampling (GAPS) network for northern sampling locations in Canada.

Annual and Quarterly Surveillance Reports were published online to provide people in Canada with information on the number of reported injuries, hazards and deaths caused by consumer products and cosmetics, including those related to chemicals.

At ECCC, monitoring and surveillance activities and milestones work progressed as planned at the beginning of the 2023-24 fiscal year, including the development of Federal Environmental Quality Guidelines (developed as benchmarks for monitoring and surveillance). National sampling campaigns under the CMP Environmental Monitoring and Surveillance Program for priority substances in air, birds, fish, sediments, water, and at municipal wastewater facilities also continued according to plan at the beginning of the 2023-24 fiscal year. Most monitoring and surveillance activities conducted under the Environmental Monitoring and Surveillance Program at ECCC progressed as planned. Data and results were shared with risk assessors and risk managers, in reports under the Stockholm Convention, and in peer-reviewed journal publications.

Collaboration, outreach and engagement

Health Canada raised public awareness about the health risks of chemicals and pollutants that may be found in and around the home via the Healthy Home Campaign, empowering people in Canada to take actions to protect themselves. Healthy Home public outreach activities continued in-person and virtually using a refined approach to reach disproportionately impacted people in Canada, including underserved rural communities, newcomers, seniors, and students. In 2023-24, 103 Healthy Home public outreach activities were delivered, resulting in 10,862 direct interactions with people in Canada. 96% of Healthy Home Learning Sessions participants reported that their knowledge about environmental health risks increased, and 86% intended to take recommended actions. In addition, social media (757,679 impressions), web visits (289,566), and a national mailout sent to 1.1 million homes in Canada, which provided a number of tips as well as a QR code to encourage people to learn more by playing the new Healthy Home Challenge resulting in 39,500 views of the online game, were other Healthy Home public outreach results in 2023-24.

In 2023-24, Health Canada improved the accessibility of CMP information by refining its approach to communication. This included collaborating with organizations, leaders, and schools on how to better leverage existing technology and develop new educational resources and tailor guidance to audience needs. This also involved improving communication materials to remove barriers to persons with disabilities (e.g., visually impaired and neurodivergent people), to raise awareness among underserved individuals and households across Canada.

Finally, Health Canada included disproportionately impacted populations in its program engagement opportunities and provided support for specific engagement opportunities with Indigenous partners and civil society organizations.

Contact information

Health Canada

Wambui Kipusi
A/Director
Healthy Environments and Consumer Safety Branch
wambui.kipusi@hc-sc.gc.ca
343-598-4679

Environment and Climate Change Canada

Thomas Kruidenier
Executive Director, Substance Prioritization, Assessment and Coordination Division (SPACD)
Science and Technology Branch
thomas.kruidenier@ec.gc.ca
613-697-4854

Joliane Lavigne
A/Director, Regulatory Operations, Policy, and Emerging Sciences Division (ROPESD)
Science and Technology Branch
joliane.lavigne@ec.gc.ca
819-962-7825

Maya Berci
Executive Director, Chemicals Management Division
Environmental Protection Branch
maya.berci@ec.gc.ca
613-852-7302

Horizontal initiative framework: Departmental funding by theme (dollars)

Horizontal initiative: Chemicals Management Plan

Shared outcome: Risks from harmful chemicals to the environment and to the health of Canadians are reduced.

Chemicals Management Plan
Name of theme Theme 1:
Chemical Risk Assessments
Theme 2:
Chemical Risk Management, Compliance Promotion and Enforcement
Theme 3:
Science-Based Decision-Making
Theme 4:
Collaboration, Outreach and Engagement
Internal Services
Theme outcome(s) Harmful chemicals are identified through risk assessments of established priority chemicals Potential human or environmental exposure to harmful chemicals is reduced CMP research and monitoring and surveillance projects provide data to inform CMP decisions Canadians use information to minimize the health and environmental risks of harmful chemicals Not applicable
Health Canada (HC)

$68,194,221 (Top-up)

$21,477,054 (Existing)

$31,979,616 (Top-up)

$17,726,922 (Existing)

$62,934,767 (Top-up)

$26,848,854 (Existing)

$22,865,441 (Top-up)

$4,327,170 (Existing)

$11,447,915 (Top-up)
Environment and Climate Change Canada

$8,918,649 (Top-up)

$28,983,039 (Existing)

$49,782,999 (Top-up)

$56,244,369 (Existing)

$22,995,255 (Top-up)

$17,220,642 (Existing)

$0

$6,803,097 (Top-up)

$8,555,904 (Existing)

Public Health Agency of Canada $0

$9,548,552 (Top-up)

$330,369 (Existing)

$0 $501,357 (Top-up) $0

Performance information

Horizontal initiative overview
Name of horizontal initiative Total federal funding allocated since last renewal (dollars) 2023–24
Planned spending (dollars)
2023–24
Actual spending (dollars)
Horizontal initiative shared outcome(s) 2023–24
Performance indicator(s)
2023–24
Target(s)
Date to achieve target 2023–24
Actual results
Chemicals Management Plan 477,686,192 159,228,731 164,257,252 Risks from harmful chemicals to the environment and to the health of Canadians are reduced Health: Levels of exposure to a selectedfootnote a group of harmful chemicals where risk management actions have been put in place Stable or downward trend (confirmed through periodic, comparative analysis of selected substances undertaken since 2010) March 2028 AR-1Footnote b
Environment: Levels of exposure within the environment of a selected group of harmful chemicals where risk management actions have been put in place Stable or downward trend (confirmed through periodic, comparative analysis of selected substances undertaken since 2010) March 2028 AR-1Footnote b
Footnote a

The Program intends to use case studies on specific substances that will examine the levels of exposure to describe the extent to which the Program has reduced risks to human health.

Return to Footnote a referrer

Footnote b

AR-1: Work is ongoing to evaluate the extent to which the Program's risk management activities are reducing exposure to harmful substances. In 2023-24, there were no new publications of performance measurement evaluation reports, however eight draft evaluations were either started or continued. Performance measurement evaluations were previously published for Bisphenol A, Polybrominated Diphenyl Ethers (PBDEs), Lead, Mercury, Isoprene, Pigment Red 3, Butanone oxide (MEKO), DEHP (human health component), nonylphenol and its ethoxylates (eco-component), dioxins and furans (health component) and dichloromethane (health component). Most of these evaluations indicate that risk management actions have been effective in reducing human and ecological exposures to the toxic chemicals examined to date.

The 2020 Performance Measurement Evaluation Strategy continues to be implemented to provide Canadians with information on the effectiveness of risk management actions in place for toxic substances. Evaluations are being conducted in accordance with the external rolling workplan, which provides a high-level workplan of performance measurement evaluations currently underway or to be initiated in coming years.

Return to Footnote b referrer

Theme horizontal initiative activities

Theme 1 – Details
Name of theme Total federal theme funding, including legacy funding, allocated since the last renewal (dollars) 2023–24
Federal theme planned spending (dollars)
2023–24
Federal theme actual spending (dollars)
Theme outcome(s) Theme performance indicator(s) Theme target(s) Date to achieve theme target 2023–24
Actual results
Chemical Risk Assessments 127,572,963 42,528,418 42,573,926 Harmful chemicals are identified in a timely manner % of the 4,363 existing chemicals that were prioritized under the Chemicals Management Plan that have been addressed 100% March 2024 99%
Theme 1 – Horizontal initiative activities
Departments Link to department's program inventory Horizontal initiative activity (activities) Total federal funding, including legacy funding, allocated to each horizontal initiative activity since the last renewal (dollars) 2023–24
Planned spending for each horizontal initiative activity (dollars)
2023–24
Actual spending for each horizontal initiative activity (dollars)
2023–24
Horizontal initiative activity expected result(s)
2023–24
Horizontal initiative activity performance indicator(s)
2023–24
Horizontal initiative activity target(s)
Date to achieve horizontal initiative activity target 2023–24
Actual results
HC
  • Heath Impacts of Chemicals
  • Consumer Product Safety
  • Food & Nutrition
  • Natural Health Products
  • Pesticides
Risk Assessment 89,671,275 29,894,522 28,920,863 ER 1.1 PI 1.1.1 T 1.1.1 March 2024 AR 1.1.1
PI 1.1.2 T 1.1.2 March 2024 AR 1.1.2
ER 1.2 PI 1.2.1 T 1.2.1 March 2024 AR 1.2.1
PI 1.2.2 T 1.2.2 March 2024 AR 1.2.2
ECCC Substances and Waste Management Risk Assessment 37,901,688 12,633,896 13,653,063 ER 1.3 PI 1.3.1 T 1.3.1 March 2024 AR 1.3.1
PI 1.3.2 T 1.3.2 March 2024 AR 1.3.2
Theme 2 – Details
Name of theme Total federal theme funding, including legacy funding, allocated since the last renewal (dollars) 2023–24
Federal theme planned spending (dollars)
2023–24
Federal theme actual spending (dollars)
Theme outcome(s) Theme performance indicator(s) Theme target(s) Date to achieve theme target 2023–24
Actual results

Chemical Risk Management, Compliance Promotion and Enforcement

165,612,827

55,204,276

61,358,306

Potential human or environmental exposure to harmful chemicals is reduced

Exposure or prevalence of a selected group of chemicals where risk management actions have been put in place

Varies by chemical

(stable or downward trend)

March 2024

AR-2footnote a

% of actions taken in a timely manner to protect the health of Canadians from substances found to be a risk to human health

100%

March 2024

95%

9 of 10 (existing)
10 of 10 (new)

% of actions taken in a timely manner to protect Canada's environment from substances found to be a risk to the environment

100%

March 2024

86%

Footnote a

AR-2: Work is ongoing to evaluate the extent to which the Program's risk management activities are reducing exposure to harmful substances. In 2023-24, there were no new publications of performance measurement evaluation reports, however eight draft evaluations were either started or continued. Performance measurement evaluations were previously published for Bisphenol A, Polybrominated Diphenyl Ethers (PBDEs), Lead, Mercury, Isoprene, Pigment Red 3, Butanone oxide (MEKO), DEHP (human health component), nonylphenol and its ethoxylates (eco-component), dioxins and furans (health component) and dichloromethane (health component). Most of these evaluations indicate that risk management actions have been effective in reducing human and ecological exposures to the toxic chemicals examined to date.

The 2020 Performance Measurement Evaluation Strategy continues to be implemented to provide Canadians with information on the effectiveness of risk management actions in place for toxic substances. Evaluations are being conducted in accordance with the external rolling workplan, which provides a high-level workplan of performance measurement evaluations currently underway or to be initiated in coming years.

Return to Footnote a referrer

Theme 2 – Horizontal initiative activities
Departments Link to department's program inventory Horizontal initiative activity (activities) Total federal funding, including legacy funding, allocated to each horizontal initiative activity since the last renewal (dollars) 2023–24
Planned spending for each horizontal initiative activity (dollars)
2023–24
Actual spending for each horizontal initiative activity (dollars)footnote a
2023–24
Horizontal initiative activity expected result(s)
2023–24
Horizontal initiative activity performance indicator(s)
2023–24
Horizontal initiative activity target(s)
Date to achieve horizontal initiative activity target 2023–24
Actual results
HC
  • Heath Impacts of Chemicals
  • Consumer Product Safety
  • Food and Nutrition
  • Natural Health Products
  • Pesticides
Risk Management, Compliance Promotion and Enforcement 49,706,538 16,568,846 20,053,702 ER 2.1 PI 2.1 T 2.1 March 2024 AR 2.1
ECCC
  • Substances and Waste Management
  • Compliance Promotion and Enforcement - Pollution
Risk Management, Compliance Promotion and Enforcement 106,027,368 35,342,456 38,179,476 ER 2.2 PI 2.2 T 2.2 March 2024 AR 2.2
ER 2.3 PI 2.3.1 T 2.3.1 March 2024 AR 2.3.1
PI 2.3.2 T 2.3.2 March 2024 AR 2.3.2
PHAC Border and Travel Health Risk Management, Compliance Promotion and Enforcement 9,878,921 3,292,974 3,125,128 ER 2.4 PI 2.4 T 2.4 March 2024 AR 2.4
Footnote a

The variance between planned and actual expenditures for Health Canada is mainly due to the reallocation of funding between themes to address priority work areas.

Return to Footnote a referrer

Theme 3 – Details
Name of theme Total federal theme funding, including legacy funding, allocated since the last renewal (dollars) 2023–24
Federal theme planned spending (dollars)
2023–24
Federal theme actual spending (dollars)
Theme outcome(s) Theme performance indicator(s) Theme target(s) Date to achieve theme target 2023–24
Actual results
Science-Based Decision-Making 129,999,518 43,338,670 43,459,977 CMP research and monitoring and surveillance projects provide data to inform CMP decisions % of research projects that inform program science-based decision-making (including priorities for risk assessment; risk management; research, monitoring and surveillance; and/or international activities related to the impacts of chemicals) 100% March 2024 100%
% of monitoring and surveillance activities that inform program science-based decision-making (including priorities for risk assessment; risk management; research, monitoring and surveillance; and/or international activities related to the impacts of chemicals) 100% March 2024 100%
Theme 3 – Horizontal initiative activities
Departments Link to department's program inventory Horizontal initiative activity (activities) Total federal funding, including legacy funding, allocated to each horizontal initiative activity since the last renewal (dollars) 2023–24
Planned spending for each horizontal initiative activity (dollars)
2023–24
Actual spending for each horizontal initiative activity (dollars)
2023–24
Horizontal initiative activity expected result(s)
2023–24
Horizontal initiative activity performance indicator(s)
2023–24
Horizontal initiative activity target(s)
Date to achieve horizontal initiative activity target 2023–24
Actual results
HC
  • Heath Impacts of Chemicals
  • Food & Nutrition
Research 48,750,852 16,250,284 16,654,902 ER 3.1 PI 3.1 T 3.1 March 2024 AR 3.1
  • Heath Impacts of Chemicals
  • Food & Nutrition
Monitoring and Surveillance 41,032,769 13,683,087 14,293,859 ER 3.2 PI 3.2 T 3.2 March 2024 AR 3.2
ECCC Substances and Waste Management Research 22,607,403 7,535,801 6,714,326 ER 3.3 PI 3.3 T 3.3 March 2024 AR 3.3
Monitoring and Surveillance 17,608,494 5,869,498 5,796,890 ER 3.4 PI 3.4 T 3.4 March 2024 AR 3.4
Theme 4 – Details
Name of theme Total federal theme funding, including legacy funding, allocated since the last renewal (dollars) 2023–24
Federal theme planned spending (dollars)
2023–24
Federal theme actual spending (dollars)
Theme outcome(s) Theme performance indicator(s) Theme target(s) Date to achieve theme target 2023–24
Actual results
Collaboration, Outreach and Engagement 27,693,968 9,225,799 7,933,475 Canadians use information to minimize the health and environmental risks of harmful chemicals % of Canadians who took recommended actions to minimize the health and environmental risks of harmful chemicals (overall; as well as disaggregated for Indigenous people and disproportionately impacted populations, such as women and visible minorities, when relevant/possible) 55% March 2027 No POR taken in 2023-24
Theme 4 – Horizontal initiative activities
Departments Link to department's program inventory Horizontal initiative activity (activities) Total federal funding, including legacy funding, allocated to each horizontal initiative activity since the last renewal (dollars) 2023–24
Planned spending for each horizontal initiative activity (dollars)
2023–24
Actual spending for each horizontal initiative activity (dollars)footnote a
2023–24
Horizontal initiative activity expected result(s)
2023–24
Horizontal initiative activity performance indicator(s)
2023–24
Horizontal initiative activity target(s)
Date to achieve horizontal initiative activity target 2023–24
Actual results
HC Health Impacts of Chemicals Outreach and Engagement 5,043,213 1,682,883 3,220,250 ER 4.1 PI 4.1.1 T 4.1.1 March 2024 AR 4.1.1
PI 4.1.2 T 4.1.2 March 2024 AR 4.1.2
PI 4.1.3 T 4.1.3 March 2024 AR 4.1.3
PI 4.1.4 T 4.1.4 March 2024 AR 4.1.4
ER 4.2 PI 4.2 T 4.2 March 2024 AR 4.2
Program Management 22,149,398 7,375,797 4,546,225 N/A N/A N/A N/A N/A
PHAC Health Impact of Chemicals Program Management 501,357 167,119 167,000 N/A N/A N/A N/A N/A
Footnote a

The variance between planned and actual expenditures for Health Canada is mainly due to the reallocation of funding between themes to address priority work areas.

Return to Footnote a referrer

Total spending, all themes
Theme Total federal funding allocated since last renewal (dollars) 2023–24 Total federal planned spending (dollars) 2023–24 Total federal actual spending (dollars)
Theme 1 127,572,963 42,528,418 42,573,926
Theme 2 165,612,827 55,204,276 61,358,306
Theme 3 129,999,518 43,338,670 43,459,977
Theme 4 27,693,968 9,225,799 7,933,475
Total, all themes 450,879,276 150,297,163 155,325,684

Horizontal initiative activity codes

Theme 1: Chemical Risk Assessments

Expected results

Health Canada

Environment and Climate Change Canada

Performance indicators

Health Canada

Environment and Climate Change Canada

Targets

Health Canada

Environment and Climate Change Canada

Actual results

Health Canada

Environment and Climate Change Canada

Theme 2: Chemical Risk Management, Compliance Promotion and Enforcement

Expected results

Health Canada

Environment and Climate Change Canada

Public Health Agency of Canada

Performance indicators

Health Canada

Environment and Climate Change Canada

Public Health Agency of Canada

Targets

Health Canada

Environment and Climate Change Canada

Public Health Agency of Canada

Actual results

Health Canada

Environment and Climate Change Canada

Public Health Agency of Canada

Theme 3: Science-Based Decision-Making

Expected results

Health Canada

Environment and Climate Change Canada

Performance indicators

Health Canada

Environment and Climate Change Canada

Targets

Health Canada

Environment and Climate Change Canada

Actual results

Health Canada

Environment and Climate Change Canada

Theme 4: Collaboration, Outreach and Engagement

Expected results

Health Canada

Performance indicators

Health Canada

Targets

Health Canada

Actual results

Health Canada

Page details

2024-12-17